Vaccine experts question fourth shot as companies seek expanded authorization

Published March 21, 2022 9:45am ET



COVID-19 vaccine makers’ requests to authorize another round of booster shots have prompted a debate splitting the pharmaceutical companies and vaccine experts who say a fourth jab is not yet needed.

Pfizer and partner company BioNTech, as well as Moderna, the makers of the two-dose mRNA vaccines, have each requested expanded use authorization from federal regulators to administer another round of booster shots to adults, bringing the total number of shots to four.

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.